14-membered macrolides derived from leucomycins
    7.
    发明授权
    14-membered macrolides derived from leucomycins 失效
    衍生自莱可霉素的14-元大环内酯类

    公开(公告)号:US06440942B1

    公开(公告)日:2002-08-27

    申请号:US09747578

    申请日:2000-12-22

    CPC classification number: C07H17/08

    Abstract: There is described a novel class of ring contracted 14-membered macrolides, and pharmaceutically acceptable salts, esters and prodrugs thereof, having antibacterial activity, compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically effective amount of a compound of the invention. There are also described synthetic processes for preparing the compounds of the invention.

    Abstract translation: 描述了具有抗菌活性的一类新颖的环缩合的14-元大环内酯及其药学上可接受的盐,酯和前药,包含治疗有效量的本发明化合物与药学上可接受的载体以及 一种通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。 还描述了制备本发明化合物的合成方法。

Patent Agency Ranking